Release Date: 2024-06-10

Interventional Radiology in Hepatobiliary Cancers

Ensar Turko (Author)

Release Date: 2024-06-10

Hepatobiliary cancers, including liver and bile duct malignancies, present significant global health challenges. Imaging modalities such as MRI and CT are pivotal for diagnosis, while percutaneous transhepatic cholangiography (PTC) aids in both diagnosis and treatment guidance under fluoroscopic control. Interventional radiology (IR) plays a crucial role in hepatobiliary cancers across diagnostic, palliative, and therapeutic domains. [...]

Media Type
    Buy from

    Price may vary by retailers

    Work TypeBook Chapter
    Published inThe Radiology of Cancer
    First Page543
    Last Page556
    DOIhttps://doi.org/10.69860/nobel.9786053359364.35
    Page Count14
    Copyright HolderNobel Tıp Kitabevleri
    Licensehttps://nobelpub.com/publish-with-us/copyright-and-licensing
    Hepatobiliary cancers, including liver and bile duct malignancies, present significant global health challenges. Imaging modalities such as MRI and CT are pivotal for diagnosis, while percutaneous transhepatic cholangiography (PTC) aids in both diagnosis and treatment guidance under fluoroscopic control. Interventional radiology (IR) plays a crucial role in hepatobiliary cancers across diagnostic, palliative, and therapeutic domains.
    Diagnostic Interventional Radiology: In IR diagnostics, imaging modalities like CT, MRI, and ultrasound are employed to characterize liver lesions and guide biopsies. Fine needle biopsy, utilizing a 21-25 gauge needle, offers rapid, cost-effective sampling with low complication rates. Core biopsy, using a 16-18 gauge tru-cut system, provides more detailed pathological information despite slightly higher risks. Percutaneous transhepatic cholangiography (PTC) assists in visualizing bile duct involvement and obtaining biopsies when endoscopic access is inadequate.
    Palliative Interventional Radiology: For palliation in obstructive jaundice from biliary obstructions (often due to malignancies), procedures aim to restore bile flow using endoscopic or percutaneous drainage. Biliary stenting may follow drainage, with self-expanding metallic stents preferred for durability and efficacy. These interventions improve quality of life by alleviating symptoms and preparing patients for further treatment.
    Therapeutic Interventional Radiology: Thermal ablation techniques like radiofrequency (RFA), microwave (MWA), and cryoablation (CrA) offer curative options for liver tumors ≤5 cm, sparing healthy tissue and minimizing complications. Transarterial chemoembolization (TACE) and transarterial radioembolization (TARE) target tumors via hepatic artery access, delivering chemotherapy or radiation internally to enhance efficacy and reduce systemic side effects.
    Conclusion: Interventional radiology serves as an essential adjunct to traditional oncological approaches in hepatobiliary cancers, offering diagnostic clarity, palliative relief, and curative treatment options. Advancements in IR techniques continue to expand therapeutic possibilities, improving outcomes and quality of life for patients worldwide.

    Ensar Turko (Author)
    Assistant Professor, Van Yuzuncu Yil University
    https://orcid.org/0000-0001-7989-5668
    3Dr. Ensar TURKO graduated from the faculty of medicine in 2014. In 2020, he completed his specialization in radiology at Yüzüncü Yıl University. Since 2022, he has been working as a lecturer in the department of radiology at Yüzüncü Yıl University. He is especially interested in oncologic interventional radiology. He also works on diagnostic radiology of hepatobiliary oncologic diseases.

    • Carney BW, Larson MC, Corwin MT, Lamba R. Imaging of Hepatobiliary Cancer. Current Problems in Cancer, 2023;100964.

    • Adalı Y, Eroğlu HA, Makav M, Karayol SS, Fındık Güvendi G, Gok M. Fine Needle Aspiration Cytology (FNAC) vs. Tru-cut Biopsy in Liver with Iron Overload: An Experimental Study. Anatolian Journal of General Medical Research 2023;33(3), 310-315.

    • Neuberger J, Patel J, Caldwell H, Davies S, Hebditch V, Hollywood C, Heydtmann M. Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology. Gut, 2020;69(8), 1382-1403.

    • Nunes TF, Tibana TK, Santos RFT, Faria BBD, Marchiori E. Percutaneous transhepatic cholangiobiopsy. Radiologia Brasileira, 2019;52, 41-42.

    • Madhusudha, KS, Gamanagatti S, Srivastava DN, Gupta AK. Radiological interventions in malignant biliary obstruction. World Journal of Radiology, 2016;8(5), 518.

    • Madhusudhan KS, Gamanagatti S, Gupta AK. Imaging and interventions in hilar cholangiocarcinoma: A review. World journal of radiology, 2015;7(2), 28.

    • Inal M, Akgül E, Aksungur E, Demiryürek H, Yagmur Ö. Percutaneous self-expandable uncovered metallic stents in malignant biliary obstruction: complications, follow-up and reintervention in 154 patients. Acta Radiologica, 2003;44(2), 139-146.

    • Almadi MA, Barkun AN, Martel M. No benefit of covered vs uncovered self-expandable metal stents in patients with malignant distal biliary obstruction: a meta-analysis. Clinical Gastroenterology and Hepatology, 2013;11(1), 27-37.

    • Reig M, Forner A, Rimola J, Ferrer-Fàbrega J, Burrel M, Garcia-Criado Á. Bruix J. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. Journal of hepatology, 2022;76(3), 681-693.

    • Chen S, Yang Y, Jiao Y, Hou L, Chang H, Liu S, Yan Z. Efficacy of drug-eluting bead transarterial chemoembolization in the treatment of colorectal cancer liver metastasis. Journal of Healthcare Engineering, 2022;2022.

    • Bzeizi KI, Arabi M, Jamshidi N, Albenmousa A, Sanai FM, Al-Hamoudi W, Alqahtani SA. Conventional transarterial chemoembolization versus drug-eluting beads in patients with hepatocellular carcinoma: a systematic review and meta-analysis. Cancers, 2021;13(24), 6172.

    • Drescher R, Köhler A, Seifert P, Aschenbach R, Ernst T, Rauchfuß F, Freesmeyer M. Clinical Results of Transarterial Radioembolization (TARE) with Holmium-166 Microspheres in the Multidisciplinary Oncologic Treatment of Patients with Primary and Secondary Liver Cancer. Biomedicines, 2023;11(7), 1831.

    • Laimer G, Schullian P, Bale R. Stereotactic thermal ablation of liver tumors: 3D planning, multiple needle approach, and intraprocedural image fusion are the key to success—A narrative review. Biology, 2021;10(7), 644.

    • Kamarinos NV, Kaye EA, Sofocleous CT. Image-guided thermal ablation for colorectal liver metastases. Techniques in Vascular and Interventional Radiology, 2020;23(2), 100672.

    • Minami Y, Aoki T, Hagiwara S, Kudo M. Tips for preparing and practicing thermal ablation therapy of hepatocellular carcinoma. Cancers, 2023;15(19), 4763.

    • Gillams A, Goldberg N, Ahmed M, Bale R, Breen D, Callstrom M, Solbiati L. Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, The Interventional Oncology Sans Frontières meeting 2013. European radiology,2015;25, 3438-3454.

    • Shady W, Petre EN, Do KG, Gonen M, Yarmohammadi H, Brown KT, Sofocleous CT. Percutaneous microwave versus radiofrequency ablation of colorectal liver metastases: ablation with clear margins (A0) provides the best local tumor control. Journal of Vascular and Interventional Radiology, 2018;29(2), 268-275.

    • Shady W, Petre EN, Gonen M, Erinjeri JP, Brown KT, Covey AM, Sofocleous CT. Percutaneous radiofrequency ablation of colorectal cancer liver metastases: factors affecting outcomes—a 10-year experience at a single center. Radiology, 2016;278(2), 601-611.

    • Pusceddu C, Mascia L, Ninniri C, Ballicu N, Zedda S, Melis L, Fancellu A. The increasing role of CTguided cryoablation for the treatment of liver cancer: A single-center report. Cancers, 2022;14(12), 3018.

    Share This Chapter!